Moderna Shares Outstanding 2017-2021 | MRNA

Moderna shares outstanding history from 2017 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Moderna shares outstanding for the quarter ending June 30, 2021 were 0.431B, a 13.12% increase year-over-year.
  • Moderna 2020 shares outstanding were 0.381B, a 15.28% increase from 2019.
  • Moderna 2019 shares outstanding were 0.331B, a 307.82% increase from 2018.
  • Moderna 2018 shares outstanding were 0.081B, a 25.76% increase from 2017.
Moderna Annual Shares Outstanding
(Millions of Shares)
2020 381
2019 331
2018 81
2017 64
2016 61
Moderna Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 431
2021-03-31 430
2020-12-31 381
2020-09-30 395
2020-06-30 381
2020-03-31 353
2019-12-31 331
2019-09-30 331
2019-06-30 329
2019-03-31 329
2018-12-31 81
2018-09-30 66
2018-06-30 66
2018-03-31 65
2017-12-31
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $183.498B $0.803B
Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71